These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16984495)

  • 1. The effects of tegaserod on oesophageal function and bolus transport in healthy volunteers: studies using concurrent high-resolution manometry and videofluoroscopy.
    Fox M; Menne D; Stutz B; Fried M; Schwizer W
    Aliment Pharmacol Ther; 2006 Oct; 24(7):1017-27. PubMed ID: 16984495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH.
    Tutuian R; Mainie I; Allan R; Hargreaves K; Agrawal A; Freeman J; Gale J; Castell DO
    Aliment Pharmacol Ther; 2006 Jul; 24(1):155-62. PubMed ID: 16803614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiology of the oesophageal transition zone in the presence of chronic bolus retention: studies using concurrent high resolution manometry and digital fluoroscopy.
    Ghosh SK; Janiak P; Fox M; Schwizer W; Hebbard GS; Brasseur JG
    Neurogastroenterol Motil; 2008 Jul; 20(7):750-9. PubMed ID: 18422907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mosapride on esophageal motility and bolus transit in asymptomatic volunteers.
    Cho YK; Choi MG; Han HW; Park JM; Oh JH; Jeong JJ; Cho YS; Lee IS; Kim SW; Choi KY; Chung IS
    J Clin Gastroenterol; 2006 Apr; 40(4):286-92. PubMed ID: 16633098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel partial 5HT3 agonist DDP733 after a standard refluxogenic meal reduces reflux events: a randomized, double-blind, placebo-controlled pharmacodynamic study.
    Choung RS; Ferguson DD; Murray JA; Kammer PP; Dierkhising RA; Zinsmeister AR; Nurbhai S; Landau SB; Talley NJ
    Aliment Pharmacol Ther; 2008 Mar; 27(5):404-11. PubMed ID: 18081732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease.
    Kahrilas PJ; Quigley EM; Castell DO; Spechler SJ
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1503-9. PubMed ID: 11069322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of sildenafil on segmental oesophageal motility and gastro-oesophageal reflux.
    Kim HS; Conklin JL; Park H
    Aliment Pharmacol Ther; 2006 Oct; 24(7):1029-36. PubMed ID: 16984496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers.
    Blonski W; Vela MF; Freeman J; Sharma N; Castell DO
    J Clin Gastroenterol; 2009 Mar; 43(3):253-60. PubMed ID: 18987553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proximal versus distal oesophageal motility as assessed by combined impedance and manometry.
    Chen CL; Cook IJ
    Dig Liver Dis; 2009 Feb; 41(2):104-9. PubMed ID: 18760980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects.
    Morganroth J; Rüegg PC; Dunger-Baldauf C; Appel-Dingemanse S; Bliesath H; Lefkowitz M
    Am J Gastroenterol; 2002 Sep; 97(9):2321-7. PubMed ID: 12358251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal solid bolus transit: studies using concurrent videofluoroscopy and manometry.
    Pouderoux P; Shi G; Tatum RP; Kahrilas PJ
    Am J Gastroenterol; 1999 Jun; 94(6):1457-63. PubMed ID: 10364007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution manometry predicts the success of oesophageal bolus transport and identifies clinically important abnormalities not detected by conventional manometry.
    Fox M; Hebbard G; Janiak P; Brasseur JG; Ghosh S; Thumshirn M; Fried M; Schwizer W
    Neurogastroenterol Motil; 2004 Oct; 16(5):533-42. PubMed ID: 15500509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impedance characteristics of normal oesophageal motor function.
    Nguyen HN; Domingues GR; Winograd R; Koppitz P; Lammert F; Silny J; Matern S
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):773-80. PubMed ID: 12811308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of nadir lower oesophageal sphincter pressure on bolus clearance assessed by combined manometry and multi-channel intra-luminal impedance measurement.
    Nguyen NQ; Ching K; Tippett M; Smout AJ; Holloway RH
    Neurogastroenterol Motil; 2010 Jan; 22(1):50-5, e9. PubMed ID: 19702840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity.
    Rodriguez-Stanley S; Zubaidi S; Proskin HM; Kralstein JR; Shetzline MA; Miner PB
    Clin Gastroenterol Hepatol; 2006 Apr; 4(4):442-50. PubMed ID: 16616348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial: effects of tegaserod on gastric motor and sensory function in patients with functional dyspepsia.
    Thumshirn M; Fruehauf H; Stutz B; Tougas G; Salter J; Fried M
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1399-407. PubMed ID: 17892526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of oesophageal motor function using combined perfusion manometry and multi-channel intra-luminal impedance measurement in normal subjects.
    Nguyen NQ; Rigda R; Tippett M; Conchillo J; Smout AJ; Holloway RH
    Neurogastroenterol Motil; 2005 Jun; 17(3):458-65. PubMed ID: 15916634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oesophageal bolus transit and clearance by secondary peristalsis in normal individuals.
    Chen CL; Szczesniak MM; Cook IJ
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1129-35. PubMed ID: 18989139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tegaserod on gut transit in male and female subjects.
    Degen L; Petrig C; Studer D; Schroller S; Beglinger C
    Neurogastroenterol Motil; 2005 Dec; 17(6):821-6. PubMed ID: 16336497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology of the esophageal pressure transition zone: separate contraction waves above and below.
    Ghosh SK; Janiak P; Schwizer W; Hebbard GS; Brasseur JG
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G568-76. PubMed ID: 16282364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.